News

Presentation on Horizon Europe by the European Commission

Presentation on Horizon Europe by the European Commission
European Commission, Funding, Horizon 2020
Funding news

The European Commission shared in early October the state of play on streamlining the numerous paper-based or electronically managed model grant agreements (MGAs). The new Corporate MGA for use as from 2021 harmonises the contractual models and guidance for all post-2020 programmes such as Horizon Europe, Digital Europe, Erasmus+, and many others. The Commission is also piloting a streamlined audit process and aims to strengthen the exploitation and dissemination of Horizon Europe outcomes.

What does the Corporate MAG look like?

With the new Corporate Model Grant Agreement the European Commission offers more user-friendly contractual agreements with a uniform structure, better readability as well as improved content and features. This will align the new MGA with the EU’s July 2018 financial regulation, a selection of legal texts relevant to the EU budget. The new Corporate MGA will be mandatory for all funding programmes and can be adapted to reflect action-specific rules.

Horizon 2020 and the new Corporate MGA

Reporting in the Corporate MGA will be divided into continuous and periodic reporting. The reduction, suspension and termination grounds will be more aligned with the new financial regulation. Additionally, the daily rate approach for personnel cost will be a fixed provision across all programmes and will have to be calculated according to the given formulas. The special rules in Annex 5 will cover issues such as security, ethics, values, IPR, communication, dissemination, open science, and visibility. Annex 5 will also list any specific rules for carrying out the relevant action.

Novelties in the new Horizon Europe MGA

  • Systems and Process Audit

The Systems and Process Audit (SPA) offers a simplified and transparent risk-based Horizon Europe control strategy that better links the different arms of control and improves risk as well as fraud detection and prevention. The aim of the SPA is to reduce the audit burden for beneficiaries. SPAs are being piloted on selected beneficiaries, with further consultation with stakeholders and EC Central Services to follow.

  • Exploitation and dissemination

Exploitation and Dissemination (D&E) places an emphasis on IP management and open science, particularly 3rd party exploitation and the use of the Horizon Results Platform within the Funding & Tenders portal to ensure the visibility of exploitable results. There will also be provisions for a results ownership list and a public emergency provision – i.e. the right to request the beneficiary to grant a non-exclusive license under fair and reasonable conditions.

Further information

Watch a recording of the workshop Novelties in Horizon Europe MGA, held by the EC on 9 October 2020, or download the presentations:

Presentation 1: General overview, state of play & financial provisions

Presentation 2: Systems and Process Audits

Presentation 3: Exploitation, IPR & Open Science in Horizon Europe

Source: The European Commission

NEWS​

Related News

Gnomon Informatics Kicks Off 2025 with a Strong Presence at Arab Health & Athens Digital Health Week!

4 Feb 2025
January was a dynamic month for Gnomon Informatics, as we showcased our innovations in digital health at two major industry events—Arab Health and Ath...

Postmodern EHR: Evolution, not revolution

4 Feb 2025
Once hailed as revolutionary, the traditional monolithic Electronic Health Record (EHR) systems now show limitations. These mega suites were designed ...

Publication by DTH-Lab & Data Solidarity Project team University of Vienna: Data solidarity operationalising public value through a digital tool

4 Feb 2025
Data governance isn't just about rules—it's about people. In this article, DTH-Lab Director, Ilona Kickbusch with co-authors Barbara Prainsack and Sel...

Digital Health Compliance Trends: Top Standards for 2025

4 Feb 2025
A study of digital health innovators asked which standards they plan to meet in 2025. Benchmark your compliance plans, by reading our article to disco...

HLTH Community & Novartis Present Latest Industry Report: Unblocking Innovations in Drug Development

4 Feb 2025
The HLTH Community & Novartis report, Unblocking Innovations in Drug Development, dives into the critical challenges hindering AI and digital inno...

Evondos Group – attending events and exhibitions in both the UK and Spain this spring

4 Feb 2025
Are you curious to test out and see the latest welfare technology that is taking the Nordics by storm? Don't miss out on which events and exhibitions ...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *